Q1 2022 Holdings
Filed 2022-05-16 | 22 holdings | $35.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $28.8M | 2,753,047 | 80.8% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $3.9M | 2,829,712 | 10.9% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.8M | 1,703,137 | 7.8% |
| Prometheus Biosciences Inc | COM | 74349U108 | $59.9K | 1,585,096 | 0.2% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $36.8K | 2,581,097 | 0.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $18.6K | 2,657,457 | 0.1% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $14.5K | 3,084,310 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $14.0K | 819,672 | 0.0% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $6.6K | 1,055,882 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $6.1K | 1,515,148 | 0.0% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $5.4K | 4,862,319 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $5.2K | 314,612 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $5.0K | 814,755 | 0.0% |
| Oncorus Inc | COM | 68236R103 | $4.3K | 2,417,436 | 0.0% |
| Akouos Inc | COM | 00973J101 | $4.0K | 836,120 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $3.8K | 5,307,751 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $3.7K | 488,635 | 0.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $3.6K | 892,057 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.4K | 62,229 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.7K | 852,888 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $1.9K | 606,629 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $206 | 222,500 | 0.0% |